Benzydamine attenuates microglia-mediated neuroinflammation and ischemic brain injury by targeting cathepsin s

Yuxin Zhang1, Lixuan Yang2, Yonghui Gan1

  • 1Department of Neurology, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China; Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.

PubMed

Insights

Benzydamine (BA) reduces neuroinflammation and brain injury after ischemic stroke by inhibiting microglia activation. This non-steroidal anti-inflammatory drug targets cathepsin S, offering a new neuroprotective strategy.

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • Microglia are key immune cells in the central nervous system, driving neuroinflammation in ischemic stroke.
  • Targeting neuroinflammation is a critical strategy for improving stroke outcomes.
  • Benzydamine (BA), an NSAID, shows anti-inflammatory potential but its role in stroke-related microglial activation is unknown.

Purpose of the Study:

  • To investigate the effect of Benzydamine (BA) on microglial activation and neuroinflammation in ischemic stroke.
  • To determine if BA can mitigate brain injury in experimental stroke models.
  • To elucidate the molecular mechanism underlying BA's action in neuroinflammation.

Main Methods:

  • Primary microglia were stimulated with lipopolysaccharide (LPS) to assess inflammatory responses.
  • Benzydamine (BA) treatment effects on inflammatory markers (e.g., IL-1β mRNA) were quantified.
  • Experimental stroke mice were used to evaluate BA's efficacy in mitigating brain injury and neuroinflammation.
  • The interaction of BA with cathepsin S (CTSS) was investigated.

Main Results:

  • BA significantly suppressed LPS-induced pro-inflammatory responses in primary microglia, reducing IL-1β mRNA levels by up to 59.1% at 10 μM.
  • BA treatment attenuated ischemic brain injury and neuroinflammation in experimental stroke mice.
  • BA was found to directly inhibit cathepsin S (CTSS) activity, reducing pro-inflammatory factor release and microglial activation.

Conclusions:

  • Benzydamine (BA) effectively suppresses microglial activation and neuroinflammation post-ischemic stroke.
  • BA acts as a cathepsin S (CTSS) inhibitor, offering a novel mechanism for neuroprotection.
  • BA presents a promising therapeutic candidate for managing ischemic stroke and associated neuroinflammation.

Related Concept Videos

Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...